Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
Topics: Coronary IVL, IVL Technology, SWAV News, Shockwave C2
What a fantastic finish! From launching the new 120-pulse Shockwave C2+ catheter in the U.S. to establishing a new Category I CPT® Add-on Code for coronary IVL, Q4 was filled with wave-making moments and positive momentum.
One highlight was the release of sex-specific outcomes data for both coronary and peripheral IVL from the DISRUPT PAD III, DISRUPT CAD III and CAD IV studies. Additionally, the DISRUPT PAD III study provided important data supporting the practice of sizing up by 10% for peripheral IVL. Look back at a few of our most noteworthy Q4 accomplishments and get excited about what’s coming in 2024 in the latest issue of the PulsePoint Newsletter.
Topics: Coronary IVL, Peripheral IVL, IVL Technology, Coronary Clinical Data, Peripheral Conferences, Peripheral Clinical Data, SWAV News, Shockwave C2, Coronary Conferences, Shockwave S4, PulsePoint Newsletter, Calcium Corner, Shockwave M5 & Shockwave M5+, Reimbursement, Treating Different Ca++ Morphologies, Female vs. Male Outcomes, Empower CAD, Reducer
From the first U.S. Shockwave C2+ case to the unveiling of the 2023 TopShock finalists, this past quarter had a lively pulse all its own. In other news, we’re very excited to share the impressive results from the 2-year DISRUPT CAD III study of IVL for Treatment of Severely Calcified Coronary Arteries.
For our international customers, there was an excellent poster session presented during ESC Congress that featured three presentations on our Coronary Sinus Reducer*. We also launched a series of real-world application videos from VAM 2023 that highlight Shockwave L6 and the benefits of using it to tackle calcium in large vessels. Dive head first into the latest PulsePoint Newsletter to learn more about the big waves made in Q3!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, Coronary Clinical Data, Peripheral Conferences, Peripheral Clinical Data, SWAV News, Shockwave C2, Coronary Conferences, Shockwave S4, PulsePoint Newsletter, Calcium Corner, Shockwave M5 & Shockwave M5+, Reimbursement, Treating Different Ca++ Morphologies, Female vs. Male Outcomes, Empower CAD, Reducer
Complex PCI can be a real headache, unless you know all the tips and tricks! In this PCR Online webinar, titled "Complex Calcified Lesions: Keep It Simple And Stay Safe", Prof Flavio Ribichini (University of Verona), Dr Claudia Cosgrove (St George's Hospital) and Dr Claudiu Ungureanu (Hôpital de Jolimont) have a lively exchange around modern PCI in calcified lesions.
Topics: Coronary IVL, IVL Technology, SWAV News, Shockwave C2
CPT® code +92972 provides an additional 2.97 Work Relative Value Units (RVU) and $140 payment for procedures involving Coronary IVL
Topics: Coronary IVL, IVL Technology, SWAV News, Shockwave C2, Reimbursement
Attending TCT in San Francisco in a few weeks? Come see how we're making waves by the Bay through a lineup of real-world evidence:
Topics: Coronary IVL, IVL Technology, Shockwave C2, Coronary Conferences
Shockwave Medical is now direct in Italy!
Topics: IVL Technology, SWAV News
Topics: Coronary IVL, IVL Technology, SWAV News, Shockwave C2
The results are in. Our expert panel has spoken. Please join us in congratulating the finalists for TopShock 2023!
Topics: Coronary IVL, IVL Technology, SWAV News, Shockwave C2, Reimbursement
Kalzium ist nicht nur oberflächlich ... manchmal muss man in die Tiefe!
Topics: Coronary IVL, IVL Technology, Shockwave C2, Coronary Conferences
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
